The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.

MLA

Roskoski, Robert, Jr. “The Role of Small Molecule Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors in the Treatment of Neoplastic Disorders.” Pharmacological Research, vol. 129, Mar. 2018, pp. 65–83. EBSCOhost, https://doi.org/10.1016/j.phrs.2018.01.021.

APA

Roskoski, R., Jr. (2018). The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders. Pharmacological Research, 129, 65–83. https://doi.org/10.1016/j.phrs.2018.01.021

Chicago

Roskoski, Robert, Jr. 2018. “The Role of Small Molecule Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors in the Treatment of Neoplastic Disorders.” Pharmacological Research 129 (March): 65–83. doi:10.1016/j.phrs.2018.01.021.